Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
OBJECTIVE: Combination chemotherapy with the two agents streptozotocin (SZT), which is a nitrosurea, and 5-fluorouracil (5-FU), an alkylating agent, has a long-established role in the treatment of neuroendocrine tumours; however, it is often accompanied by considerable toxicity, and it has not been...
Egile Nagusiak: | Kaltsas, G, Mukherjee, J, Isidori, A, Kola, B, Plowman, P, Monson, J, Grossman, AB, Besser, G |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2002
|
Antzeko izenburuak
-
The role of chemotherapy management of malignant in the nonsurgical neuroendocrine tumours
nork: Kaltsas, G, et al.
Argitaratua: (2001) -
The role of chemotherapy in the nonsurgical management of malignant neuroendocrine tumours.
nork: Kaltsas, G, et al.
Argitaratua: (2001) -
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
nork: Kaltsas, G, et al.
Argitaratua: (1998) -
The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
nork: Kaltsas, G, et al.
Argitaratua: (2001) -
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
nork: Kaltsas, G, et al.
Argitaratua: (2005)